“…Importantly, the OPTIMUL assay was more sensitive to defects of thromboxane pathway. 49 Overall, results suggested promise as a screening/diagnostic test, especially considering multiple advantages over traditional LTA platforms that include Finally, the development of revolutionary microfluidic flow chambers provides an opportunity to examine coagulation and a complete spectrum of platelet function (adhesion, activation, secretion, aggregation, contraction, and procoagulant activity). The ability to manipulate the system permits the user ability to tailor conditions (type, size, strength of triggering surfaces, flow chamber dimensions, flow rates, flow patterns, wall shear rates, etc.)…”